Bloomberg
As much as 85% of capital expenditure investment and up to half of research and development spending are at risk, based on a survey of 18 international companies
Read More
European pharma companies warn of exodus to US as tariffs loom
Bloomberg
09:20
As much as 85% of capital expenditure investment and up to half of research and development spending are at risk, based on a survey of 18 international companies
